Discover

MYO
Myomo, Inc.
1.04
900 x 1.02
1400 x undefined
bid
ask
+
0.00
0.00%
1150 @ 06:34 AM
1.04 +0.00 (0.00%)
Ytd14.29%
1y-51.85%
1.04
day range
1.12
0.60
52 week range
2.38
Open1.03Prev Close1.04Low1.04High1.12Mkt Cap40.18M
Vol479.71KAvg Vol772.37KEPS-0.36P/EN/AForward P/E-120.60
Beta1.55Short Ratio3.45Inst. Own46.24%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-0750-d Avg1.04200-d Avg0.921yr Est7.67
Earning
DateForEstimateReportedSurprisesurprise %
2024-11-062024-09-0.04-0.030.0125.00%
2024-08-062024-06-0.07-0.030.0457.14%
2024-05-082024-03-0.09-0.1-0.01-11.11%
2024-03-072023-12-0.05-0.07-0.02-40.00%
2023-11-072023-09-0.08-0.060.0225.00%
2023-08-092023-06-0.04-0.04N/AN/A
Upgrade / Downgrade
DateFirmActionFromTo
2024-12-13Craig-HallumUpgradeBuyBuy
2024-11-12Ascendiant CapitalUpgradeBuyBuy
2024-08-19Ascendiant CapitalUpgradeBuyBuy
2024-08-12HC Wainwright & Co.UpgradeBuyBuy
2024-07-31Craig-HallumUpgradeBuy
2024-07-09Lake StreetUpgradeBuyBuy
Profile
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Insider Holder
DateNameRelationQuantityDescription
2024-06-04CROWLEY THOMAS ALOYSIUS JRDirector42.03KStock Award(Grant)
2024-06-04GETZ HEATHER CDirector12.03KStock Award(Grant)
2024-06-04GUDONIS PAUL RChief Executive Officer959.85KStock Award(Grant)
2024-06-04HENRY DAVID AChief Financial Officer414.42KStock Award(Grant)
2024-06-04KIRK THOMAS FDirector248.53KStock Award(Grant)
2024-06-04KNAPP AMY KDirector91.65KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Rosalind Advisors, Inc.3.02M18.22M9.99%
2024-09-29AIGH Capital Management LLC2.78M16.76M9.19%
2024-09-29Vanguard Group Inc1.24M7.49M4.11%
2024-09-29Essex Investment Management Co LLC899.14K5.42M2.97%
2024-09-29Legato Capital Management LLC307.27K1.85M1.02%
2024-09-29Geode Capital Management, LLC229.10K1.38M0.76%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Vanguard Total Stock Market Index Fund866.17K5.22M2.86%
2024-09-29Vanguard Extended Market Index Fund346.16K2.09M1.14%
2024-10-30Fidelity Extended Market Index Fund127.53K769.01K0.42%
2024-07-301290 Fds-1290 Essex Small Cap Growth Fd114.76K692.02K0.38%
2024-09-29Bridgeway Funds Inc-Ultra Small Company Market Fund67.50K407.03K0.22%
2024-10-30iShares Micro Cap ETF63.40K382.28K0.21%
Split
SplitDate
1 : 302020-01-31